Example #1: The Company is subject to the informational requirements of the Securities Exchange Act of 1934, as amended (the “ Exchange Act ”), and in accordance therewith files reports, proxy statements and other information including annual and quarterly reports on Form 10-K and 10-Q (the “ 1934 Act Filings ”) with the Securities and Exchange Commission (the “ Commission ”).
Expected output: 'entities: [{'span': 'Securities Exchange Act of 1934', 'entity': 'Legislation/Act'}, {'span': 'Exchange Act', 'entity': 'Legislation/Act'}, {'span': 'Form 10-K', 'entity': 'Miscellaneous'}, {'span': '10-Q', 'entity': 'Miscellaneous'}, {'span': '1934 Act Filings', 'entity': 'Miscellaneous'}, {'span': 'Securities and Exchange Commission', 'entity': 'Government'}]'

Example #2: If a properly executed proxy is returned and no choice is specified, the shares will be voted FOR the election of the nominees as listed in this Joint Proxy Statement.
Expected output: 'entities: []'

Example #3: The letter should indicate that you are a Fund shareholder and note the Fund or Funds that you own.
Expected output: 'entities: []'

Example #4: The cases were consolidated in the District Court for the Southern District of New York for pretrial purposes.
Expected output: 'entities: [{'span': 'District Court for the Southern District of New York', 'entity': 'Court'}]'

Example #5: This Information Statement has been filed with the Securities and Exchange Commission and is being furnished, pursuant to Section 14C of the Securities Exchange Act of 1934, as amended (the “ Exchange Act ”), to the holders (the “ Stockholders ”) of the common stock, par value $ .0001 per share (the “ Common Stock ”), of Comcam, Inc., a Delaware Corporation (the “ Company ”), to notify such Stockholders that on or about March 5, 2010, the Company received written consents in lieu of a meeting of Stockholders from holders of 683,952,500 shares representing approximately 91 % of the 744,640,134 shares of the total issued and outstanding shares of voting stock of the Company (the “ Majority Stockholders ”) to authorize 1-for-85 reverse stock split (pro-rata reduction of outstanding shares) of our issued and outstanding shares of Common Stock (the “ Reverse Stock Split ”).
Expected output: 'entities: [{'span': 'Securities and Exchange Commission', 'entity': 'Government'}, {'span': 'Securities Exchange Act of 1934', 'entity': 'Legislation/Act'}, {'span': 'Exchange Act', 'entity': 'Legislation/Act'}, {'span': 'Comcam, Inc.', 'entity': 'Business'}, {'span': 'Delaware', 'entity': 'Location'}]'

Example #6: Investors may obtain a free copy of the proxy statement, as well as other filings containing information about Chemical Financial and OAK, free of charge from the SEC's website (www.sec.gov); by contacting Chemical Financial Corporation, 333 East Main Street, PO Box 569, Midland, MI 48640-0569, Attention: Ms. Lori A. Gwizdala, Investor Relations, telephone 800-867-9757 or by contacting O.A.K. Financial Corporation, 2445 84th Street, SW, Byron Center, MI 49315, Attention: Mr. James A. Luyk, Investor Relations, telephone 616-599-7419.
Expected output: 'entities: [{'span': 'Chemical Financial', 'entity': 'Business'}, {'span': 'OAK', 'entity': 'Business'}, {'span': 'SEC', 'entity': 'Government'}, {'span': 'Chemical Financial Corporation', 'entity': 'Business'}, {'span': 'East Main Street', 'entity': 'Location'}, {'span': 'Midland', 'entity': 'Location'}, {'span': 'MI', 'entity': 'Location'}, {'span': 'Lori A. Gwizdala', 'entity': 'Person'}, {'span': 'O.A.K. Financial Corporation', 'entity': 'Business'}, {'span': '84th Street, SW', 'entity': 'Location'}, {'span': 'Byron Center', 'entity': 'Location'}, {'span': 'James A. Luyk', 'entity': 'Person'}]'

Example #7: Audit Committee Pre-Approval Policies and Procedures.
Expected output: 'entities: []'

Example #8: We, the undersigned directors of Acorda Therapeutics, Inc., hereby severally constitute and appoint Ron Cohen our true and lawful attorney with full power to him to sign for us and in our names in the capacities indicated below, this Registration Statement on Form S-8 filed herewith and any and all subsequent amendments to said registration statement, and generally to do all such things in our names and on our behalf in our capacities as directors to enable Acorda Therapeutics, Inc. to comply with the provisions of the Securities Act of 1933, as amended, and all requirements of the Securities and Exchange Commission, hereby ratifying and confirming our signatures as they may be signed by our said attorney to said registration statement and any and all amendments thereto.
Expected output: 'entities: [{'span': 'Acorda Therapeutics, Inc.', 'entity': 'Business'}, {'span': 'Ron Cohen', 'entity': 'Person'}, {'span': 'Form S-8', 'entity': 'Miscellaneous'}, {'span': 'Securities Act of 1933', 'entity': 'Legislation/Act'}, {'span': 'Securities and Exchange Commission', 'entity': 'Government'}]'

Example #9: IPOs On October 1, 2003, the Commission filed a complaint (the “ IPO Complaint ”) against J.P. Morgan Securities Inc. (predecessor to JPMS, “ JPMSI ”) in the United States District Court for the District of Columbia (the “ D.C. District Court ”) in a civil action captioned Securities and Exchange Commission v. J.P. Morgan Securities Inc..
Expected output: 'entities: [{'span': 'IPO Complaint', 'entity': 'Miscellaneous'}, {'span': 'J.P. Morgan Securities Inc.', 'entity': 'Business'}, {'span': 'JPMS', 'entity': 'Business'}, {'span': 'JPMSI', 'entity': 'Business'}, {'span': 'United States District Court for the District of Columbia', 'entity': 'Court'}, {'span': 'D.C. District Court', 'entity': 'Court'}, {'span': 'Securities and Exchange Commission', 'entity': 'Government'}]'

Example #10: The Board of Directors The Corporate Trust Services division of Wells Fargo Bank, National Association: We have examined management s assessment, included in the accompanying Assessment of Compliance with Applicable Servicing Criteria, that The Corporate Trust Services division of Wells Fargo Bank, National Association (the Company) complied with the servicing criteria set forth in Item 1122 (d) of the Securities and Exchange Commission s Regulation AB for publicly-issued (i.e., transaction-level reporting initially required under the Securities Exchange Act of 1934, as amended) residential mortgage-backed securities, commercial mortgage-backed securities, and other asset-backed securities, for which the Company provides master servicing, trustee, securities administration, or paying agent services, excluding transactions issued by any agency or instrumentality of the U.S. government or any government sponsored entity and further excluding the transactions issued prior to 2006 for which Wells Fargo outsources all material servicing activities (as defined by Regulation AB) (the Platform), except for servicing criteria 1122 (d) (4) (ii), 1122 (d) (4) (iv), 1122 (d) (4) (v), 1122 (d) (4) (viii), 1122 (d) (4) (ix), 1122 (d) (4) (x), 1122 (d) (4) (xi), 1122 (d) (4) (xii), and 1122 (d) (4) (xiii), which the Company has determined are not applicable to the activities it performs with respect to the Platform, as of and for the twelve months ended December 31, 2009.
Expected output: 'entities: [{'span': 'Wells Fargo Bank, National Association', 'entity': 'Business'}, {'span': 'Securities and Exchange Commission', 'entity': 'Government'}, {'span': 'Regulation AB', 'entity': 'Legislation/Act'}, {'span': 'Securities Exchange Act of 1934', 'entity': 'Legislation/Act'}, {'span': 'U.S.', 'entity': 'Location'}, {'span': 'Wells Fargo', 'entity': 'Business'}]'

